Indikation for behandling med NeoRecormon af nefrosklerotiske patienter, som endnu ikke får dialyse, skal fastlægges individuelt, da en mulig acceleration af progredierende nyresvigt ikke kan udelukkes. ###>The indication for treatment with NeoRecormon of nephrosclerotic patients not yet undergoing dialysis should be defined individually, as a possible acceleration of progression of renal failure cannot be ruled out with certainty.